NeoGraph Analytics
BiotechnologyNorth America2023 – 2032

Electronic Lab Notebook Market Size, Share and Trends Analysis

The global Electronic Lab Notebook market was valued at $1.2 billion in 2023 and is projected to reach $2.7 billion by 2032, growing at a CAGR of 9.5%.

Revenue, 2023

$1.2B

Forecast, 2032

$2.7B

CAGR, 2024-2032

9.5%

Report Coverage

North America

Code: electronic-lab-notebook-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Market Overview

The global Electronic Lab Notebook market is experiencing robust growth, driven by digital transformation in life sciences R&D, with a projected value of $2.7 billion by 2032 at a 9.5% CAGR.

Market Stage

High growth

Adoption Level

Growing

Key Trends

Cloud adoption acceleratingAI integration for predictive analyticsRegulatory compliance as primary driverCollaboration tools becoming standard
02

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 9.5%

Base Year (2023)

$1.3B

Forecast (2032)

$2.7B

CAGR (2024-2032)

9.5%

Regional Market Analysis
Market share and growth rate by region

North America

#1
Share: 45.0%CAGR: 10.5%

Largest market: USA

Europe

#2
Share: 30.0%CAGR: 8.5%

Largest market: Germany

03

Market Dynamics

  • Stricter regulatory requirements for data integrity
  • Rise of distributed research teams
  • Demand for real-time data sharing
  • Cost reduction through automation
04

Market Segmentation

By Application

  • Drug Discovery & Development
  • Bioprocess Development
  • Other

By End User

  • Pharmaceuticals
  • Biotechnology
  • Academic & Research Institutions
  • Others
05

Regional Analysis

1

North America

Lead: USA
CAGR: 10.5%Share: 45.0%

The United States dominates with 35% market share, driven by robust pharmaceutical R&D investments and early adoption of digital solutions.

2

Europe

Lead: Germany
CAGR: 8.5%Share: 30.0%

Germany leads with 10% market share, supported by strong regulatory frameworks and government-funded digital transformation initiatives.

3

Asia Pacific

Lead: China
CAGR: 12.5%Share: 25.0%

China drives growth with 8% market share, fueled by government biotech subsidies and expanding contract research capabilities.

Country-Level Analysis

CountryShareGrowth
USA
25.0%
+10.5%
Germany
10.0%
+8.5%
China
8.0%
+12.5%
06

Competitive Landscape

B

Benchling

USA

LeaderApprox. $100M

Specializes in cloud-native ELN with AI-driven analytics and collaboration tools for biotech R&D

Benchling ELNBenchling Data PlatformAI-Powered Experimental Design Module
L

LabArchives

USA

ChallengerApprox. $50M

Offers comprehensive ELN solutions with strong regulatory compliance features

LabArchives ELNLabArchives CloudRegulatory Compliance Suite
I

IDBS

UK

FollowerApprox. $300M (parent company)

Provides integrated R&D platforms with ELN capabilities for enterprise-scale pharma

IDBS ELNIDBS EnterpriseAdvanced Data Analytics Module
B

BioTuring

USA

Challenger

Focuses on AI-integrated ELNs for predictive experimental design

T

Thermo Fisher Scientific

USA

Follower

Offers ELN capabilities within broader laboratory informatics suites

D

Dotmatics

USA

Follower

Provides ELN solutions integrated with data analysis tools for pharma

07

Recent Developments

25
2025Benchling

Launched AI-driven predictive analytics module for experimental optimization, integrating with CRISPR and protein design workflows.

24
2024LabArchives

Acquired Veeva Systems' ELN assets to enhance regulatory compliance features for biopharma clients.

24
2024BioTuring

Introduced quantum computing integration for accelerated molecular simulation in ELN platform.

23
2023Thermo Fisher Scientific

Expanded ELN capabilities with new bioprocess development modules for cell therapy manufacturing.

23
2023IDBS

Partnered with AWS to offer HIPAA-compliant ELN solutions for clinical trial data management.

08

Regulatory Landscape

FDA 21 CFR Part 11GDPRISO 27001HIPAA
09

Frequently Asked Questions

The global Electronic Lab Notebook market was valued at $1.2 billion in 2023.
The market is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2032.
North America currently holds the largest market share at 45%, driven by the United States.
Regulatory compliance requirements, particularly FDA 21 CFR Part 11 and EU Annex 11, are the primary drivers for ELN adoption in pharmaceutical and biotech R&D.